The move comes amid reports of disappointing results from trials for a treatment against the variant behind the current outbreak
Surveillance efforts against mpox are being ramped up globally, as trials for a new treatment showed disappointing results against the variant driving the current outbreak.
The European Centre for Disease Prevention and Control (ECDC) on Friday raised its risk level assessment for mpox, formerly known as monkeypox, from low to moderate. The decision came after Sweden reported the first case of clade Ib outside Africa.
